Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoid Product for Endometriosis
NCT06477406Phase 2Active, not recruiting
- Sponsor
- McLean Hospital
- Start
- Feb 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in endometriosis, sponsored by McLean Hospital. Started Feb 2024; status: active, not recruiting.
02
Drugs
cannabidiol
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT06477406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06477406.